Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar desktop iconMarkt Monitor

Crucell« Terug naar discussie overzicht

CRUCELL KONDIGT PER.C6-LICENTIEOVEREENKOMST

4 Posts
| Omlaag ↓
  1. [verwijderd] 15 maart 2007 14:09
    Crucell Announces PER.C6® Licensing Agreement with Pfizer Animal Health




    Leiden, The Netherlands, March 15, 2007- Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) and Pfizer Animal Health today announced the signing of a research license agreement for PER.C6®. The license agreement allows Pfizer Animal Health to use Crucell's industry-leading PER.C6® cell technology in the production of a non-disclosed veterinary vaccine. Pfizer Animal Health has an option to convert the research license into a commercial agreement. Financial details were not disclosed.

4 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.